Skip to main content

Find Clinical Trials

Home
Conditions
Thoracic Neoplasms

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,051 public trials 1,842 recruiting studies

Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Terminated

Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists

NCT03412058

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations: Institut Bergonie Bordeaux, France

Centre Hospitalier de Caen Caen, France

Centre Jean Perrin Clermont-Ferrand, France

Centre Hospitalier Inter. de Creteil Créteil, France

View all 19 locations

View Trial Details

Terminated

Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer

NCT03662074

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +10 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Suspended

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

NCT06694454

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Suspended

Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer

NCT05642195

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +17 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Suspended

Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS)

NCT07102212

Conditions: Alzheimer Disease, Anxiety Disorders, Behavior, +56 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Suspended

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

NCT03987555

Conditions: Adnexal Diseases, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +58 more
Locations: Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Suspended

Biodistribution & Pharmacokinetic of Position Emission Tomography (PET) Radiopharmaceutical 18F C SNAT4

NCT04017819

Conditions: Cancer, Lung Cancer, Lung Diseases, +6 more
Locations: Stanford University Stanford, California, United States

View Trial Details

Suspended

Feasibility Testing of a Dyadic Exercise Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers

NCT07234799

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Withdrawn

Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

NCT07353957

Conditions: Lung Cancer - Non Small Cell Non-Squamous, Lung Cancer - Non Small Cell Squamous, Lung Diseases, +6 more
Locations: Florida Cancer Specialists - North St. Petersburg, Florida, United States

Memorial Sloan Kettering Cancer Center Long Island City, New York, United States

Tennessee Site 2 Chattanooga, Tennessee, United States

Tennessee Site 1 Nashville, Tennessee, United States

View all 24 locations

View Trial Details

Withdrawn

A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

NCT07075627

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Bronchial Neoplasms, +21 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details